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Natural products traditionally have played an important role in drug discovery and formed the basis of most early 
medicines. Medicinal plants and drugs derived from them have been explored extensively for their antidiabetic potential. 
Extensive literature survey revealed that the family cucurbitaceae of higher plants has contributed a lot in traditional system 
of medicines for developing antidiabetic formulations. The most discussed Momordica charantia and Cucumis sativus are 
some examples. However, many cucurbitaceous taxa are yet to be explored. The objectives of the present study are to gather 
data from literature on the antidiabetic potential of cucurbitaceous plants with their traditional usage and in-vitro screening 
of different extracts and fractions of collected cucurbitaceous plants for their antidiabetic activity in the glucose utilization 
assay (GUA) on L6 cell line. Based on literature survey, a list of 32 plant species of cucurbitaceae family was prepared, 
which have been reported for antidiabetic activity or mentioned in ethnomedicinal and traditional system of medicines for 
antidiabetic potential. A total of 15 crude extract and their 75 fractions were prepared from 9 collected cucurbitaceous plants 
and their parts and screened against differentiated rat skeletal (L6) muscle cells in glucose uptake assay. Eight 
extracts/fractions from 4 plants (Cucumis callosus fruit, Luffa echinata fruit, Coccinia indica fruit and Cucurbita species 
aerial part) were found active in antidiabetic screening. The best antidiabetic activity was found in chloroform fraction of 
Luffa echinata fruit. After bioactivity guided column fractionation of this active fraction, the fraction M010/S/3/5 showed 
maximum activity in glucose uptake assay. EC50 was calculated as 0.59 μg/mL showed potent antidiabetic compound. 
Present study revealed that there is huge potential in cucurbitaceous plants for developing antidiabetic drug. 
Keywords: Antidiabetic activity, Cucurbitaceous plants, Ethnomedicinal use, In-vitro screening 
Abbreviations: Cpm-counts per minute, KDa-kilodalton, o/n-overnight, ppt-pellet, Sup.-supernatant 
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Diabetes mellitus is a group of metabolic disorders in 
which the body does not produce enough or does not 
properly use insulin, resulting in hyperglycemia. Type 
I is the result of the body's failure to produce enough 
insulin while Type II diabetes is a result of insulin 
resistance. Type II diabetes is more prevalent and 
generally diagnosed in adult1. The International 
Diabetes Federation estimates that approximately  
425 million adults around the world have diabetes. 
This total is expected to rise to 629 million by the 
year 2045. Insulin (Humulin, Novolin), Sulfonylureas, 
Alpha-glucosidase inhibitors, Biguanide class, 
Meglitinide class, Thiazolidinedione class, Dipeptidyl 
peptidase-4 inhibitors are the some of the antidiabetic 
drugs available in market for the treatment of  
Type II diabetes. Few of these drugs may cause 
hypoglycemia; patients may become resistant to these 
drugs, or develop gastrointestinal problems, and 
hepatotoxicity2. Naturally derived antidiabetic drugs 
such as metformin have the advantage that they do not 
cause significant side effects and show less toxicity, 
unlike chemical drugs such as sulfonylurea.  
India is rich in plant resources and traditional 
ayurvedic knowledge. There is a vast potential for 
natural product based discovery and development of 
drug candidates with good therapeutic efficacy and 
low toxicity3. Medicinal and aromatic plants have 
been widely used for treatment of many diseases in a 
traditional way for several generations. Selection of 
higher plants as candidates for drug development is 
based on the information from traditional medicine 
(ethnomedicine)4. Plants and plant derived bioactive 
compounds have an advantage in this area based  
on their long-term use by humans, and low human 
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toxicity. Chemical diversity of secondary plant 
metabolites that results from plant evolution may be 
equal or superior to that found in synthetic 
combinatorial chemical libraries3. 
A large number of plants used in the traditional 
medicine have now become a part of the modern 
world health care system. Natural products offer large 
structural diversity, and modern techniques for 
separation, structure elucidation, screening and 
combinatorial synthesis have led to revitalization of 
plant products as sources of new drugs5. As the Type 
II diabetes epidemic grows, so does the need for 
newer, better drugs. There are currently more than 30 
diabetes drugs in nine classes in the market. Total  
22 drugs were approved by FDA for diabetes during 
1995-2008 but none of them is plant based  
drug6. Currently, plant based few compounds are in 
different stages of clinical trials for diabetes from 
Hoodia gordonii, Artemisia dracunculus, Berberis 
aristata & Momordica charantia7. 
The number of higher plant species is estimated at 
250,000. Of these, only about 6% have been screened 
for biologic activity and a reported 15% have been 
evaluated phytochemically4. About 43,879 species of 
higher plants have already been reported for their 
ethnomedicinal, chemical & pharmacologic uses8. 
Most common drug for diabetes Metformin is of plant 
origin4. Berberine which is obtained from Berberis 
aristata has been shown to have antidiabetic 
properties, although its mode of action is not known. 
Metabolic effects of berberine have been investigated 
in two animal models of insulin resistance and in 
insulin-responsive cell lines. Berberine reduced body 
weight and caused a significant improvement in 
glucose tolerance without altering food intake in 
db/db mice9. Cucurbitane glycosides, momordicosides 
Q, R, S, and T and karaviloside XI, were isolated 
from bitter melon (Momordica charantia) and 
exhibited beneficial effects to diabetes and obesity. 
Cucurbitane triterpenoids, the characteristic 
constituents of M. charantia, may provide leads as a 
class of therapeutics for diabetes and obesity10. 
According to a survey based on data from 
NAPRALERT (Natural Products Alert), about 1200 
plants have been studied experimentally or used 
ethnopharmacologically to treat diabetes mellitus. 
Plant families most commonly represented for 
antidiabetic activity were Fabaceae, Asteraceae, 
Lamiaceae, Liliaceae, Poaceae & Euphorbiaceae11. 
The extensive literature survey revealed that the 
family Cucurbitaceous of higher plants has 
contributed a lot in traditional  
Indian system of medicines for developing  
antidiabetic formulations12. The Momordica charantia, 
popularly known as karela is one of the best  
examples. M. charantia was also used in traditional 
Indian and Chinese medicines to cure diabetes and 
antigluconeogenic activity of cucurbitacins from  
M. charantia has also been established12,13. Citrullus 
colocynthis (Cucurbitaceae) was also described for 
ethnomedicinal use in diabetes and now well known 
for antidiabetic effects after pharmacological studies14.  
Online literature search shows that there are at  
least 32 species of the family Cucurbitaceae that  
have been reported to possess antidiabetic potential 
(Table 1) and studied for their antidiabetic activity in 
pharmacological studies. Table 1 summarizes the 
details of cucurbitaceous plants evaluated for 
antidiabetic activity and their ethanomedicinal 
information. It was also found that alkaloid rich and 
bitter plants have a maximum possibility to show 
hypoglycemic effects. A large number of species 
belonging to family Cucurbitaceae are yet to be 
explored. Our objective was to screen unexplored 
plant species from Cucurbitaceae family with a view 
to identify the promising glucose uptake modulators. 
In the present study, in-vitro screening using glucose 
utilization bioassay in differentiated L6 myotubes  
was performed for evaluating antidiabetic activity in  
9 species of family Cucurbitaceae.  
 
Methodology 
 
Plant collection and processing 
The selection of plant species was carried out on 
the basis of literature available on ethnomedicinal, 
ayurvedic and other traditional systems of medicines, 
online search through various databases and 
phytochemical works and the patent search  
on the species of interest for their antidiabetic 
properties. About 20 selected species that qualified 
our criteria of selection for further evaluation  
were targeted for collection. However, depending  
on the distribution pattern and availability finally  
9 taxa from family Cucurbitaceae were collected from 
the State of Maharashtra, India. A total of 15 plant 
parts weighing 3-4 kg of fresh material of each were 
collected from the forests of Thane and different 
localities in Mumbai and surrounding areas (Table 2). 
The plant parts were dried separately in shade  
using dehumidifier. Taxonomically identified voucher  
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Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
1. Benincasa  
hispida 
Stem 
Fruit 
Stem 
Chloroform extract 
Ethanol extract 
Aqueous extract 
Hypoglycemic activity in  
normal male Wistar rats28  
Decrease in glucose,  
triglyceride and insulin  
levels in plasma on  
dexamethasone induced  
insulin resistance in mice29 
Significant reduction in the  
blood glucose levels in  
alloxan-induced diabetic 
 rabbits30 
Asthma, cough, hemorrhages, peptic 
ulcer, diabetes, epilepsy and nervous 
system disorder16; Respiratory disease, 
heart diseases, diabetes mellitus, 
urinary diseases and gastrointestinal 
problems31; Fruits are used as a 
laxative, diuretic, tonic, aphrodisiac, 
cardiotonic, urinary calculi, blood 
disease, insanity, epilepsy, 
schizophrenia and other psychologic 
disorders31; Main ingredient in 
kusmanda lehyam, in Ayurvedic 
system of medicine, dyspepsia, 
vermifuge, burning sensation, heart 
disease, and urinary disease30. 
2. Bryonia alba Root 
Root 
Trihydroxyoctadec- 
adienoic acids 
Ethanol extract 
Restores the disordered  
lipid metabolism of  
alloxan-diabetic rats32 
Hypoglycaemic activity in  
alloxan-induced diabetes in rats33 
Constipation, stiffness of joints due to 
rheumatism, headache, bronchitis, 
pneumonia, measles, synovial 
inflammation and pneumonia34. 
3. Citrullus 
colocynthis 
Fruit 
Fruit 
Fruit 
Seed 
Petroleum ether  
extract  
Ethanol extract 
Aqueous extract  
Aqueous extract  
Reduction in blood glucose  
levels in streptozotocin  
induced diabetic rats35 
Decrease in the levels of total 
cholesterol, triglycerides, free fatty 
acids and phospholipids in serum 
and liver of treated diabetic rats36 
Decrease of blood glucose from  
132 to 93 mg/100 mL after 24 h  
of normoglycaemic rabbits37  
Reduction in plasma level of  
AST (aspartate dehydrogenase)  
and LDH (lactic dehydrogenase) 
significantly in streptozotocin 
induced diabetic rats38  
Asthma, bronchitis, ascites, ulcers, 
leucoderma, constipation, tumors and 
hypoglycemia, fruits are cooling, 
carminative, carthartic, antipyretic and 
anthelmintic16; Diabetes, constipation, 
asthma, bronchitis, leprosy, jaundice, 
joint pain, cancer, mastitis, 
indigestion, dysentery, gastroenteritis 
and colic pain , common cold, cough, 
toothache, wounds, hypertension, 
hepatoprotective, leaves for the 
treatment of jaundice and asthma14 
4. Citrullus 
 lanatus 
Seed Globulins Significant anti-hyperglycaemic 
activity in male Wistar rats by the 
oral glucose tolerance test39  
Ripe fruits as cooling, strengthening, 
diuretic, stomachic, purifies the blood, 
aphrodisiac, astringent, biliousness, 
sore eyes, scabies and itching, fruit 
juice as an antiseptic in typhus fever 
and purgative, seeds are tonic to the 
brain40. 
5. Coccinia  
grandis 
Leaf 
Leaf 
Aqueous extract 
Methanol extract 
Antihyperglycemic effect in  
alloxan induced diabetic  
Wistar rats41 
Significant antihyperglycemic 
activity in Swiss albino mice  
on oral glucose tolerance tests42 
Fresh root extract as antidiabetic12; 
Fruits in diabetes, aphrodisiac, 
biliousness and disease of the blood. 
Juice of whole plant is used in 
diabetes, anorexia, asthma, fever, 
dropsy, catarrh, epilepsy and 
gonorrhea, whole plant in diabetes 
mellitus. Fruit and leaves are 
prescribed in the treatment of  
snake-bite40 
     (Contd.)
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Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity (Contd.) 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
6. Coccinia indica 
(Synonym: 
Coccinia grandis, 
Coccinia 
cordifolia) 
Aerial 
parts 
Leaf 
Aerial 
parts 
 
95% ethanolic  
extracts 
60% Ethanolic  
extracts 
Ethanol extract 
Dried extract 
Blood glucose lowering effect in 
alloxan diabetic albino rats19  
Decreased level of blood glucose 
and fatty acid in streptozotocin 
(SZT) induced diabetic rats43 
Antihyperglycemic effects in  
STZ induced diabetes in  
Sprague–Dawley rats17  
In a clinical study, restored the 
raised activity of lipoprotein  
lipase and the levels of G-6 
phosphotase and LDH in  
diabetic patients44 
Antidiabetic property, used for  
treating diabetes mellitus in 
Ayurveda17; Leaf extract and  
aerial parts have hypoglycemic  
and antihyperglycemic effect 17,45; 
Ayurveda and Unani system of 
medicine for treatment of diabetes, 
skin eruptions, tongues sore,  
earache, etc46 
7. Cucumis  
callosus 
Fruit Ethanol extract Antihyperglycemic effect in  
alloxan induced diabetic rat47 
Prevent insanity, seeds are cooling  
and astringent and useful in bilious 
disorder40; Cucumis callosus is a wild 
relative of Cucumis melo48.  
8. Cucumis melo Leaf Methanol and aqueous 
extract 
Anti-hyperglycemic activity  
in streptozotocin induced 
hyperglycemia model49 
Leaves are used in flatulence, fever, 
cough, anemia, jaundice, leprosy, 
diabetes, antiobesity, constipation, 
ascites, bronchitis and amentia; Fruit 
pulp is liver tonic, cardio tonic, 
appetizer, anthelmintic, thermogenic, 
expectorant and intellect promoting; 
Roots are used as emetic and purgative49; 
Seed powder for diabetes50. 
9. Cucumis 
metuliferous 
Fruit 
Fruit 
Fruit pulp extract 
Glycoside fraction 
Decrease in the blood glucose 
concentration in alloxan induced 
hyperglycemic rats51 
Significant dose-dependent 
reductions in blood glucose 
concentration in albino rats with 
alloxan-induced diabetes52 
Roots are used to treat Appendicitis; 
Stomach ache53. 
10. Cucumis 
prophetarum 
Fruit 
Fruit 
Aqueous extract 
N-Trisaccharide 
Effective antidiabetic activity in  
α -amylase assay and  
α -glucosidase assay54  
Antihyperglycemic activity in 
streptozotocin(STZ)–nicotinamide 
(NA) induced type 2 diabetic rats55 
Inflammatory-related 
problems54. 
11. Cucumis 
 sativus 
Fruit  
peel 
 
Fruit 
 
 
Fruit 
Ethanolic extract 
 
 
Aqueous extract 
 
 
Ethanolic extract 
 
Antidiabetic activity in alloxan 
induced diabetes mellitus in 
 male mice20  
Anti-hyperglycemic effect by 
subcutaneous glucose tolerance  
tests on 27 healthy rabbits56 
Hypoglycemic effects on alloxan 
induced diabetic rats57  
Constipation, indigestion, seeds are 
tonic, anthelmintic and diuretic16; Skin 
problems, anti-diarrheal, detoxicant 
and anti-gonorrheal agents18; Fruit is 
direct used in demulcent. Fried seeds 
are used in cooling tonic, diuretic and 
anthelmintic. Leaves along with cumin 
seeds administrated in throat 
affections40. 
12. Cucumis  
trigonus 
Fruit Aqueous extract Beneficial effects in reducing  
the elevated blood glucose level  
and lipid profile of STZ-induced-
diabetic rats58 
Leprosy, fever, jaundice, diabetes, 
cough, bronchitis, anaemia, constipation 
and other abdominal disorders58; Fruit 
juice for treating diabetes50. 
     (Contd.)
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Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity (Contd.) 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
13. Cucurbita  
ficifolia 
 
Fruit 
Fruit 
Aqueous extract 
Traditional 
preparations 
Methanol extract 
Anti-hyperglycemic effect by 
subcutaneous glucose tolerance 
 tests on 27 healthy rabbits56 
Hypoglycaemic effect similar to  
that of tolbutamide in healthy and 
mildly diabetic rabbits59 
Antihyperglycemic activity in 
streptozotocin-induced 
 experimental diabetes in rats60  
Hemorrhoids, fever and wound cure16  
14. Cucurbita  
maxima 
Aerial 
parts 
Fruit 
powder 
Methanol extract 
 
Antidiabetic activity in  
Wistar albino rats against 
streptozotocin61 
Reduce blood glucose levels 
significantly in the 20 NIDDM 
diabetics patients62 
Antitumor, antidiabetic, 
antihypertensive, antibacterial, anti-
inflammatory and immunomodulatory 
effects61; Fruit is used 
in diuretic, tonic, inflammations and 
boils. Fried seeds are used in 
anthelmintic, diuretic and tonic40. 
15. Cucurbita 
moschata 
Seeds 
Stem 
Globulins 
Crude extract 
Significant anti-hyperglycaemic 
activity in male Wistar rats  
by the oral glucose tolerance  
test39 
Hypoglycaemic effect in-vivo in 
streptozotocin-induced diabetic 
mice63  
Folk medicine for measles, jaundice, 
insomnia, colic, and treatment of 
amoebas64; Leaf paste is used in 
biliousness and burning sensation, 
fruit is 
cooling, astringent to the bowels, 
laxative, good for teeth, throat, eyes, 
seeds are diuretic, tonic, bronchitis, 
fever, good for the kidney and the 
brains40. 
16. Cucurbita pepo Fruit 
 peel 
 
Fruit 
Ethanolic extract 
 
 
Fruit powder 
Antidiabetic activity in alloxan 
induced diabetes mellitus in male 
mice20  
Hypoglycaemic effects in  
alloxan-induced diabetic rats65 
Astringent, blood purification, leprosy, 
sore chests, bronchitis, hemoptysis and 
fever16; Fruit is cooling, astringent to 
the bowels, laxative, and good for 
teeth, throat and eyes. Leaf paste is 
used in biliousness and burning 
sensation. Seeds are 
diuretic, tonic, bronchitis, fever, good 
for the kidney and brains40. 
17. Ibervillea  
sonorae 
 
Root 
 
 
 
Root 
Traditional 
preparations (freeze-
dried decoction) 
 
Aqueous extract 
Significantly lowered the glycemia 
of mild alloxan-diabetic mice  
and rats, but did not in severe 
alloxan-diabetic rats66  
Antidiabetic properties by 
stimulating the glucose uptake in 
human preadipocytes by a PI3K-
independant pathway67  
Treatment of type 2 diabetes in 
México67; Roots are widely used as a 
topical antibiotic, cathartic, 
antirheumatic, and hypoglycaemic68. 
18. Lagenaria 
siceraria 
Fruit 
Aerial  
 
parts 
 
 
Fruit 
Ethanol extract 
 
 
Methanol extract 
 
 
Methanol extract 
Antihyperglycemic activity in  
induced in alloxan-induced  
diabetic rats 69 
Antihyperglycemic activity  
on streptozotocin induced 
diabetes in rats70  
α-Glucosidase inhibitory  
activity22 
Cardiotonic, general tonic and diuretic 
properties, diabetes mellitus70; General 
tonic in Ayurveda, cardiotonic16; 
Ulcers, pain, fever, asthma, bronchial 
disorders, fruit is traditionally used for 
its cardioprotective, cardiotonic, 
general tonic, aphrodisiac, purgative, 
diuretic properties71. 
     (Contd.)
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Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity (Contd.) 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
19. Luffa  
acutangula 
Fruit 
Fruit 
 
 
 
Fruit 
 
 
Fruit 
Chloroform and  
Ethyl acetate extract 
Methanol extract 
 
 
 
Methanol and aqueous 
extract 
Ether, chloroform, 
ethanol and aqueous 
extracts 
α-Glucosidase inhibitory  
activity22 
Increased mucosal glycoprotein  
and antioxidant enzyme level in 
gastric mucosa of streptozotocin 
(STZ) induced diabetic rats24  
Antidiabetic activity in STZ  
induced diabetic rats72 
Antidiabetic activity73 
Jaundice, splenic enlargement and 
laxative72; Jaundice, insect bites, fruit 
powder for swollen hemorrhoids, 
seeds is used for dysentery while the 
juice of roasted young fruit is used to 
cure headache; diuretic properties, 
expectorant, laxative, and purgative; 
hypoglycemic agent, bitter tonic; used 
in the enlargement of spleen. Roots for 
kidney stones, swelling of the lymph 
glands. Leaves are useful in dysentery, 
inflammation of spleen, ringworms, 
piles and leprosy74 
20. Luffa aegyptica 
Syn: Luffa 
cylindrica 
Leaf 
 
Seeds 
Aqueous and Ethanol 
extract 
Ethanol extract 
Significant antidiabetic activity 
in alloxan induced diabetic rats75  
Decreased blood glucose level  
with a potency similar to that  
of the biguanide, metformin in  
STZ diabetic rats76 
Leaf juice cures conjunctivitis77; Fruit 
in jaundice78. 
21. Luffa tuberosa Fruit Aqueous extract Antidiabetic property in 
streptozotocin (STZ)  
induced diabetic rats79 
Used for the treatment of diabetes 
mellitus79; Abortifacient80 
22. Momordica 
balsamina 
Seeds 
Fruit 
Various 
plant 
parts 
Aqueous extract 
Fruit pulp powder and 
aqueous methanolic 
extract (90%) 
Aqueous and  
Organic extract 
Significant antihyperglycemic 
potential in STZ-induced  
diabetes models in rats81 
Antidiabetic activity in 
streptozotocin (STZ) induced 
diabetic Wistar rats82 
Antidiabetic activity in in vitro 
studies using glucose utilisation 
method1 
Snake bite83; Purgative, vermifuge and 
fruit is used in diabetes82. 
23. Momordica 
charantia 
Fruit 
Fruit 
Fruit 
Seed 
Fruit 
juice 
95% ethanolic extracts 
Ethanolic extract, 21 
cucurbitane compounds 
Ethyl acetate extract 
Acetone extract 
---- 
Blood glucose lowering activity  
in alloxan diabetic albino rats19  
Compounds 1, 10, 11, and 12  
(at 25–100 μM) showed 
concentration- 
dependent inhibition on  
glucose production from liver 
cells; compounds 
11 and 12 (at 100 μM) showed 
around 20–30% inhibition 
on PEPCK activity13 
α-Glucosidase inhibitory activity22 
Antilipolytic activity in isolated  
rat adipocytes84 
In a clinical study, administration  
of 100 mL of fruit juice improved 
glucose tolerance in 73% of test 
subjects following an oral glucose 
tolerance test85 
Anthelmintic, carminative, purgative, 
antiemetic, anaemia, jaundice, cholera, 
malaria and unripe fruit for diabetes16; 
Fruit extract as antidiabetic12; Stem 
and root are used to treat toothaches, 
diarrhea, furuncle, and diabetes. Fruit 
is used to cure diarrhea, furuncle, heat 
stroke, and diabetes and seeds are used 
to remedy asynodia13 
     (Contd.)
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Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity (Contd.) 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
24. Momordica 
cymbalaria 
Fruit 
powder 
Fruit 
Aqueous extract Significant blood glucose  
lowering effect in alloxan-induced 
diabetic rats and reduced the  
level of cholesterol and  
triglycerides in diabetic rats86 
Significant antihyperglycemic as 
well as antihyperlipidemic effects in 
the alloxan-induced diabetic rats87 
Fruits for gastric ulcer, roots have 
been used by the natives of north 
Karnataka and Andhra Pradesh to treat 
gynecological ailments and also to 
induce abortions88 
25. Momordica  
dioica 
Fruit 
Fruit 
Fruit 
Ethyl acetate and 
alcoholic extracts 
Aqueous extract 
Aqueous, hexane, 
chloroform, and 
ethanol 
extract 
Antidiabetic activity in  
alloxan induced diabetic rats89 
Oral hypoglycemic effect in  
rat model90 
Fall in fasting blood glucose in 
glucose tolerance test in normal 
healthy rats91 
Antiseptic, anthelmintic, astringent, 
febrifuge and spermicidal92; Fresh fruit 
juice is prescribed for hypertension and 
fruit cooked in oil is used for treating 
diabetes92, 93; Fruits have diuretic, 
laxative, hepatoprotective, 
antivenomous, antihypertensive, anti-
inflammatory, antiasthmatic, antipyretic, 
antileprosy, antidiabetic, and 
antidepressant properties. Leaves have 
antihelminthic, aphrodisiac, 
antihemorroidal, hepatoprotective, 
antibronchitic, antipyretic, antiasthmatic, 
and analgesic properties93 
26. Momordica  
foetida 
Various 
plant 
parts 
Aqueous and  
Organic  
Extracts 
Foetidin 
Antidiabetic activity in in vitro 
studies using glucose utilisation 
method1 
Lowered blood glucose levels in 
normal but not in diabetic rats94 
Diabetes, piles, haemorrhoid, 
gastroenteritis, snake bites, pregnancy, 
small pox, stomach ache, dropsy, 
fever, ear ache, anthelmintic, 
tumours95 
27. Mukia 
madaraspatana 
(Synonym: 
Melothria 
Maderaspatana) 
 
Entire 
plant 
Stem  
Roots 
Aerial 
parts 
Ethanol extract 
Ethanol and  
aqueous extracts 
Methanol extract 
Ethanol extract 
Blood glucose level decreased  
in alloxan induced male  
Wistar albino rats96 
Hypoglycemic activity by increase 
in glucose uptake in L-6 skeletal 
muscle cells in vitro97 
Normal blood glucose was  
achieved in alloxan induced  
diabetic rats98 
Antihyperglycemic effects in  
STZ induced diabetes in Sprague–
Dawley rats17  
Diuretic, antipyretic, stomachic gentle 
aperients and antiflatulent, 
antiasthmatic, anti-inflammatory, 
antidiabetic and antibronchitis,  
tooth-ache, vertigo and biliousness99, 
100. Inflammatory diseases101;  
Seeds, roots and leaf juice were  
used to treat diabetes102  
28. Praecitrullus 
fistulosus 
Fruit peel Ethanol extract Antidiabetic activity in alloxan 
induced diabetes mellitus in  
male mice20  
Leaves are used in blood pressure103 
29. Sechium  
edule 
Fruit Ethyl acetate extract α-Glucosidase inhibitory activity22  Kidneys, circulatory systems and 
inflammatory diseases16. 
30. Telfairia 
occidentalis 
Seed 
Leaf 
Seed 
Ethanol extract 
Ethanol extract 
Globulins 
Hypoglycemic effects in  
alloxan diabetic rats104 
Significant reduction in blood 
glucose level in alloxan-induced 
diabetic rats105  
Anti-hyperglycaemic activity in 
male Wistar rats by the oral 
glucose tolerance test39  
Cholesterolemia, liver problems and 
impaired immune system105 
     (Contd.)
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specimens were deposited in the herbarium of Natural 
Products Botany Department, Piramal Life Sciences 
Ltd, Mumbai.  
 
Extraction and fractionation 
Dried plant materials were pulverized to a course 
powder. The pulverized material was taken for 
extraction. The dried coarse powder (100 g) was 
soaked in 1 L DCM (dichloro methane): MeOH 
(Methanol) (1:1) in a flask for 8 h at room temprature. 
The extract is filtered with Whatman filter paper and 
the filtrate-1 was collected. The same extraction 
procedure was repeated one more time with remaining 
residue and filtrate-2 was collected. The filtrate-1 & 
filtrate-2 were pooled and the organic crude extracts 
(A) were concentrated by using rotary vacuum 
evaporator (BUCHI, Switzerland) at 400C & further 
dried in speed vac (Savant, Germany) at an ambient 
temperature for overnight. The plant marc was re-
extracted sequentially with water and was frozen 
dried (H). All the dried extracts were stored at room 
temprature. (22–240C). The crude DCM: MeOH 
extract (A) (1 g) was dissolved in 25 mL of water: 
methanol (9:1). The sequential fractionation was 
Table 1 — Ethnomedicinal use of cucurbitaceous plants and their evaluation for antidiabetic activity (Contd.) 
S. No. Plant Parts 
used 
Extracts/ Active 
constituents 
Activity Ethnomedicinal use 
31. Trichosanthes 
cucumerina 
Seeds 
Whole 
plant 
Aerial 
parts 
Fruit 
95% Ethanolic  
extracts;  
Aqueous extract;  
Hot water extract 
Ethyl acetate extract 
Blood glucose lowering activity  
in alloxan diabetic albino rats19  
Improved glucose tolerance and 
tissue glycogen in non insulin 
dependent diabetes mellitus  
induced rats106 
Improvement in glucose tolerance 
and increase in liver glycogen and 
adipose tissue triglyceride levels in 
normal and streptozotocin–induced 
diabetic rats107 
α-Glucosidase inhibitory activity22 
Hepatoprotective, antidiabetic, 
cytotoxic, anti inflammatory and 
larvicidal effects108; stem decoction, 
aerial parts and leaves were used 
in the treatment of diabetes and 
inflammatory diseases106; 
Anthelmintic, bronchitis, cathartic, 
headache and boils, seeds are 
antifebrile, anthelmintic and useful for 
stomach disorder16 
32. Trichosanthes 
dioica 
Leaf 
Leaf 
 
Aqueous extract 
Aqueous extract 
 
Reduced blood glucose  
significantly in streptozotocin 
induced hyperglycemic rats109 
Hypoglycemic effects in 
streptozotocin (STZ)-induced  
sub- and mild-diabetic rats110 
 
Epilepsy, alopecia, skin disease and 
diabetes mellitus109; Fresh fruit juice is 
used as cooling and laxative. Fruit is 
also used in spermatorrhoea. Leaves 
are aperients, tonic and febrifuge; used 
in the cases of enlarge liver and 
spleen. Fruit is febrifuge, laxative, 
antibilious40 
 
Table 2 — Extraction of collected cucurbitaceous plants and their extracted yield 
S. No. Plant Name Plant Part Dry weight (g) Extracts Extract Yield (g) 
1. Trichoanthes cucumerina Aerial 250 M001/A 10.940 
2. Mukia maderaspatana Aerial 50 M002/A 3.794 
3. Momordica dioica Aerial 150 M003/A 8.984 
4. Trichoanthes cucumerina fruits 100 M004/A 17.027 
5. Benincasa hispida Aerial 250 M005/A 9.641 
6. Cucumis callous Aerial 115 M006/A 4.411 
7. Cucumis callous fruits 20 M007/A 2.871 
8. Lagenaria siceraria Aerial 250 M008/A 11.433 
9. Luffa echinata Aerial 300 M009/A 4.541 
10. Luffa echinata fruits 60 M010/A 9.100 
11. Coccinia indica Aerial 345 M011/A 15.686 
12. Coccinia indica fruits 25 M012/A 2.294 
13. Cucurbita sp. Aerial 235 M013/A 9.376 
14. Cucurbita sp. fruits 25 M014/A 2.499 
15. Trichoanthes cucumerina (whole plant) 100 M015/A 28.155 
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performed in separatory funnel using different organic 
solvents viz. petroleum ether (B), chloroform (S) and 
ethyl acetate (C) (4 X 25 mL) with a view to separate 
the range of highly polar to non-polar compounds. 
Solvent fractions were concentrated by using rotary 
vacuum evaporator at 400C and aqueous alcoholic 
fraction (D) was lyophilized using Freeze dryer 
(Edwards, Germany). All the crude extracts (A) and 
their fractions (B, S, C, D & H) were dissolved in 
DMSO (dimethyl sulfoxide) (20 mg/mL) and taken 
for screening for antidiabetic activity in glucose 
utilization assay (GUA). All the organic solvents used 
for extraction and fractionation were of analytical 
grade and supplied by Merck, Mumbai. 
 
Cell culture and glucose uptake assay 
L6, rat skeletal muscle (myoblast) cells were 
obtained from ATCC (American type culture 
collection) and used for screening of antidiabetic 
compounds in GUA. L6 cells are adherent in property 
and fuse in culture to form multinucleated myotubes 
and striated fibres. Growth medium used for L6 cell 
line was MEM- (minimum essential medium α 
modification) (HyClone), with 10% FBS (fetal bovine 
serum). Trypsin- EDTA treatment was performed to 
disrupt the cell monolayers at confluency. Cells were 
incubated with layer of Trypsin-EDTA at 370C for  
30 s and resuspended in 10 mL of fresh growth media. 
Number of cells were counted using haemocytometer 
and quantity of cells were calculated to add to new  
T-175 flask (Nunc, Denmark) or 24 well culture 
plates (Nunc, Denmark). Cultures were incubated at 
37°C in 5% CO2 environment.  
L6 cells were seeded into 24 well culture plates at 
the density of 25 x 104 cells /well in MEM- with 10% 
serum & 0.7% antibiotic (penicillin-streptomycin), and 
were cultured for 48 h in 5% CO2 at 370C. For 
differentiation, L6 myoblasts were cultured in MEM- 
containing 2% FBS for 4 days to promote the fusion 
into myotubes and about 80-90% of the myoblasts were 
fused into myotubes15. Differentiated myotubes were 
serum starved for 4 h and then incubated with the 
plant extracts and fractions for overnight. Sample 
treatment was done by adding 2.5 µL of extracts and 
fractions or rosiglitazone (positive control) to the 
medium in the respective wells. After 18 h of plant 
extract treatment, 200 nM insulin was added after 
aspiration of media from plates and incubated for  
25 min at 370C. Then 22 μL per well radioactive 
glucose solution (2-Deoxy-D-[1-14C] Glucose from 
Amersham, UK) was added. Mixed the content by 
gentle tapping from the sides and incubated for  
15 min at 370C. Thereafter, wells were washed twice 
with cold KRPH (Krebs-Ringer Phosphate Hepes) 
buffer after aspiration of the solution from the well. 
Then 0.1% SDS was added in each well and allowed 
15 min for lysis. Each well was scrapped & 
transferred in scintillation vial with scintillation  
fluid and scintillation counting was performed.  
Cpm was measured using Packard Tri-Carb  
Liquid Scintillation Counter. The compounds  
that promoted the glucose consumption more  
than 2-fold relative to 200 nM insulin were 
considered as active compounds. 
 
Bioactivity guided fractionation 
HPTLC (high performance thin layer 
chromatography) analysis was performed for active 
extracts to optimize the best solvent system for 
chromatographic separation on TLC Silica gel 60 F254 
plates (Merck, Germany). 10% Methanol in 
chloroform, 5% methanol in chloroform and 20% 
ethyl acetate in petroleum ether solvent systems were 
used for better resolution of compounds. Resolved 
components were visualized under UV light and also 
on exposure to vanillin sulphuric acid spray reagent. 
Column chromatography was employed for the 
purification of active solvent fraction of plant crude 
extract. Combi Flash Sq 16 X (Isco) with RediSep  
12 g Flash column was used for chromatography. 
Extract was dissolved in MeOH & CHCl3 and 
adsorbed with equal amount of silica gel with  
200-400 mesh size. Dried it on rotavapor and  
loaded in column of combi flash. Elution was 
performed with the concomitant increase in 
concentration of methanol and all the eluted fractions 
were subjected to TLC (Thin Layer Chromatography) 
analysis. Bioassay guided fractionation was 
performed for assessing the antidiabetic activity of 
each fraction and then next round of separation was 
done for each active fraction. A fractionation process 
was performed several times and many sub-fractions 
were obtained. GUA was performed for each sub 
fraction eluted and grouped according to their 
chemical profiles analyzed by TLC.  
 
Statistical analysis 
Data collection, tabulation and initial analysis were 
performed by using Microsoft Excel 2007 and 
GraphPad Prism 4.0 was utilized for analysis of 
results, graph preparations and calculation of EC50. 
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Results 
 
Plant extracts and fractions 
The 15 plant parts from 9 plant species of family 
Cucurbitaceae produced a total of 15 crude extracts 
(Table 2) and 75 fractions using different organic 
solvents (Table 3). Extraction from Trichosanthes 
cucumerina whole plant produced maximum crude 
extract yield of about 28.15 g from 100 g of plant 
material while minimum crude extract yield  
was obtained from Luffa echinata aerial part of  
about 4.54 g from 300 g of plant material. One gram 
crude extract of each plant sample was taken  
for fractionation and the yield of each fraction  
along with solvent used is listed in Table 3. All the 
crude extracts and their fractions (total 90 samples) 
Table 3 — Fractionation of plant extracts and yield 
S. No. Fractions Solvent used Yield (mg) 
1 M001/B Petroleum ether 253 
2 M001/S Chloroform 208 
3 M001/C Ethyl acetate 52 
4 M001/D Aqueous alcoholic  354 
5 M001/H DCM-MeOH sequential water 653 
6 M002/B Petroleum ether 207 
7 M002/S Chloroform 195 
8 M002/C Ethyl acetate 61 
9 M002/D Aqueous alcoholic 249 
10 M002/H DCM-MeOH sequential water 3436 
11 M003/B Petroleum ether 110 
12 M003/S Chloroform 126 
13 M003/C Ethyl acetate 150 
14 M003/D Aqueous alcoholic 395 
15 M003/H DCM-MeOH sequential water 3416 
16 M004/B Petroleum ether 673 
17 M004/S Chloroform 73 
18 M004/C Ethyl acetate 39 
19 M004/D Aqueous alcoholic 5 
20 M004/H DCM-MeOH sequential water 11591 
21 M005/B Petroleum ether 269 
22 M005/S Chloroform 125 
23 M005/C Ethyl acetate 56 
24 M005/D Aqueous alcoholic 213 
25 M005/H DCM-MeOH sequential water 3240 
26 M006/B Petroleum ether 266 
27 M006/S Chloroform 88 
28 M006/C Ethyl acetate 72 
29 M006/D Aqueous alcoholic 14 
30 M006/H DCM-MeOH sequential water 4086 
31 M007/B Petroleum ether 183 
32 M007/S Chloroform 231 
33 M007/C Ethyl acetate 35 
34 M007/D Aqueous alcoholic 403 
35 M007/H DCM-MeOH sequential water 2535 
36 M008/B Petroleum ether 188 
  (Contd.) 
Table 3 — Fractionation of plant extracts and yield (Contd.) 
S. No. Fractions Solvent used Yield (mg) 
37 M008/S Chloroform 86 
38 M008/C Ethyl acetate 62 
39 M008/D Aqueous alcoholic 346 
40 M008/H DCM-MeOH sequential water 2485 
41 M009/B Petroleum ether 157 
42 M009/S Chloroform 54 
43 M009/C Ethyl acetate 49 
44 M009/D Aqueous alcoholic 220 
45 M009/H DCM-MeOH sequential water 4024 
46 M010/B Petroleum ether 77 
47 M010/S Chloroform 219 
48 M010/C Ethyl acetate 248 
49 M010/D Aqueous alcoholic 225 
50 M010/H DCM-MeOH sequential water 4503 
51 M011/B Petroleum ether 453 
52 M011/S Chloroform 59 
53 M011/C Ethyl acetate 38 
54 M011/D Aqueous alcoholic 446 
55 M011/H DCM-MeOH sequential water 3738 
56 M012/B Petroleum ether 191 
57 M012/S Chloroform 4 
58 M012/C Ethyl acetate 15 
59 M012/D Aqueous alcoholic 21 
60 M012/H DCM-MeOH sequential water 2502 
61 M013/B Petroleum ether 289 
62 M013/S Chloroform 60 
63 M013/C Ethyl acetate 67 
64 M013/D Aqueous alcoholic 312 
65 M013/H DCM-MeOH sequential water 3939 
66 M014/B Petroleum ether 217 
67 M014/S Chloroform 83 
68 M014/C Ethyl acetate 48 
69 M014/D Aqueous alcoholic 16 
70 M014/H DCM-MeOH sequential water 3328 
71 M015/B Petroleum ether 406 
72 M015/S Chloroform 35 
73 M015/C Ethyl acetate 35 
74 M015/D Aqueous alcoholic 182 
75 M015/H DCM-MeOH sequential water 3716 
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were taken for primary screening in GUA for 
antidiabetic activity.  
 
In-vitro screening 
All the 90 plant extracts and their fractions were 
evaluated with GUA in differentiated L6 myotubes 
for antidiabetic activity. Samples were dissolved in 
DMSO at the concentration of 20 mg/mL before 
primary screening. Out of 90 extracts screened,  
8 extracts from 4 plant species i.e., Cucumis callosus 
fruit, Luffa echinata fruit, Coccinia indica fruit and 
Cucurbita species aerial part were found active in 
primary screening in glucose uptake assay for 
antidiabetic activity (Fig. 1). All 8 active extracts in 
preliminary screening (M007/S, M010/A, M010/S, 
M010/C, M012/A, M012/S, M012/C & M013/S) were 
taken for repeat screening or secondary screening in 
dose dependent manner at concentrations 30, 10,  
3 and 1 µg/mL. All of these 8 extracts from 4 plant 
species showed antidiabetic activity at 30 and  
10 µg/mL conc and 3 extracts (M010/A, M010/S & 
M012/C) from 2 plant species were found active at  
3 µg/mL conc (Fig. 2). These screening results 
indicate that chloroform fraction of Cucumis callosus 
fruit (M007/S), chloroform and ethyl acetate fraction 
of Luffa echinata fruit (M010/S & M010/C), 
chloroform and ethyl acetate fraction of Coccinia 
indica fruit (M012/S & M012/C) and chloroform 
fraction of Cucurbita sp. aerial part (M013/S) 
exhibited activity in GUA. Almost all the fractions of 
Luffa echinata fruit extract (M010) demonstrated 
higher antidiabetic activity in GUA.  
 
Antidiabetic activity after bioassay guided fractionation  
Sequential fractionation was performed with 
different solvents and analyzed for antidiabetic 
activity at each step. The most active chloroform 
fraction of Luffa echinata fruit extract (M010/S)  
was taken for column fractionation and flash 
chromatography was carried out using combi flash Sq 
16x. Total 7 pooled fractions (M010/S/1, M010/S/2, 
M010/S/3, M010/S/4, M010/S/5, M010/S/6 & 
M010/S/7) after chromatography were screened  
again for antidiabetic activity and fractions  
3 (M010/S/3) & 4 (M010/S/4) were shown activity at 
10 & 1 µg/mL conc in GUA (Fig. 3). Both the 
fractions (M010/S/3 & M010/S/4) exhibited 
significant increase in bioactivity at 10 µg/mL conc. 
Most active sub-fraction M010/S/3 was taken for 
fractionation again using flash chromatography to get 
pure compound. Collected 39 tubes were pooled into 
5 fractions (M010/S/3/1, M010/S/3/2, M010/S/3/3, 
M010/S/3/4 & M010/S/3/5) after TLC analysis. Of 
these 5 fractions, fraction 5 (M010/S/3/5) has shown 
maximum antidiabetic activity in GUA at 10 and 1 
μg/mL conc (Table 4). Bioassay guided column 
fractionation of active extract lead to the purification 
and isolation of fraction 4 (M010/S/3/4) & fraction  
5 (M010/S/3/5). Fraction 5 (M010/S/3/5) showed 
maximum glucose uptake in GUA and was 
comparable with insulin and rosiglita zone. 
 
EC50 of most active fraction M010/S/3/5  
Most active fraction M010/S/3/5 was taken again 
for measuring activity in GUA at 8-point dilutions for 
 
 
Fig. 1 — Active plant extracts and their fractions in primary 
antidiabetic screening in glucose uptake assay (GUA) 
 
 
 
Fig. 2 — Dose dependent repeat analysis of extracts and fractions 
active in primary screening in GUA 
 
 
Fig. 3 — Antidiabetic activity in GUA after CombiFlash 
fractionation of most active extract M010/S (chloroform fraction 
of Luffa echinata fruit) 
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calculating EC50. Fraction M010/S/3/5 has shown 
higher antidiabetic activity at 10, 3, 1 & 0.3 μg/mL 
conc on comparison to rosiglitazone (Fig. 4). Purified 
fraction 5 (M010/S/3/5) demonstrated significantly 
increased antidiabetic activity in GUA on comparison 
to positive control rosiglitazone. EC50 was calculated 
for the most active fraction M010/S/3/5 and found to 
be as 0.59 μg/mL (Fig. 4). EC50 value has shown that 
the fraction M010/S/3/5 could become more potent 
antidiabetic compound than the rosiglitazone. Purified 
and most active fraction M010/S/3/5 (chloroform 
fraction of Luffa echinata fruit extract) could be further 
purified and isolated using HPLC (High Performance 
Liquid Chromatography) and taken for structure 
elucidation using NMR (Nuclear Magnetic Resonance 
Spectroscopy) and MS (Mass Spectroscopy).  
 
Discussion and Conclusion 
The family cucurbitaceae of higher plants have 
about 130 genera and about 800 species and contains 
many plants which have medicinal importance. 
Dhiman et al., 2012 reviewed extensively about 
medicinal value of the family cucurbitaceae for their 
use in traditional medicine and pharmacological 
studies. Momordica charantia, Cucurbita ficifolia, 
Citrullus colocynthis, Lagenaria siceraria, Benincasa 
hispida and Trichosanthes cucumerina plants from 
family Cucurbitaceae have been mentioned for the 
treatment for diabetes in his review16. Apart from this 
many other literature and some patents are available 
for antidiabetic activity of Cucurbitaceous plants. A 
comprehensive list of 32 plant species of 
Cucurbitaceae family has been tabulated based on 
ethnomedicinal use and their evaluation for 
antidiabetic activity (Table 1). Cucumis sativus, 
Coccinia indica and Momordica charantia are some 
of the plants from cucurbitaceae family are mentioned 
extensively in Ayurvedic system of medicine for their 
antidiabetic properties and also reported in many 
other literatures including Pub Med and USPTO. 
Medicinal plants have been used extensively by native 
population for cure of various diseases and formed the 
principal constituent for Indian traditional medicine 
system. Herbal formulations of Momordica charantia 
and Coccinia grandis were used by tribal people of 
Sikkim and Darjeeling Himalayas for treating 
diabetes12. A wide range of plant- derived compounds 
have been demonstrated for their possible use in the 
treatment of Type II diabetes.  
There are immense examples of cucurbitaceous 
plants known for their antidiabetic properties and used 
in traditional medicinal system in many countries. 
Present study also emphasized the importance of 
cucurbitaeous plants for the treatment of Type II 
diabetes. Cucumis callosus fruit, Luffa echinata fruit, 
Coccinia indica fruit and Cucurbita species aerial part 
Table 4 — Fractionation and antidiabetic activity of most active fraction 3 of M010/S (chloroform fraction of Luffa echinata fruit) 
S. No. Fractions Solvent Used Conc  
(µg/ml) 
Fold increase  
over ctrl 
Rosiglitazone, fold 
increase at 30 μM 
Antidiabetic 
Activity 
1 M010/S/3/1 CombiFlash Fr. CHCl3:MeOH 10 1.4 2.1 Not active 
  CombiFlash Fr. CHCl3:MeOH 1 1.1 2.1 Not active 
2 M010/S/3/2 CombiFlash Fr. CHCl3:MeOH 10 3.4 2.1 Active 
  CombiFlash Fr. CHCl3:MeOH 1 2.7 2.1 Active 
3 M010/S/3/3 CombiFlash Fr. CHCl3:MeOH 10 3 2.1 Active 
  CombiFlash Fr. CHCl3:MeOH 1 2.5 2.1 Active 
4 M010/S/3/4 CombiFlash Fr. CHCl3:MeOH 10 2.7 2.1 Active 
  CombiFlash Fr. CHCl3:MeOH 1 2.8 2.1 Active 
5 M010/S/3/5 CombiFlash Fr. CHCl3:MeOH 10 3.4 2.1 Active 
  CombiFlash Fr. CHCl3:MeOH 1 2.8 2.1 Active 
 Insulin ctrl    1.3  
 
 
 
Fig. 4 — EC50 of the most active fraction M010/S/3/5 of Luffa 
echinata fruit 
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were found beneficial for antihyperglycemic activity 
in in-vitro studies on L6 myotubes in GUA. First time 
we are reporting about antidiabetic activity of 
chloroform fractions of Luffa echinata and Cucumis 
callosus fruit in in-vitro studies. Coccinia indica17 and 
Cucumis sativus18 have been accounted earlier by 
many researchers for their antihyperglycemic activity 
and our results also showed that the fruit of Coccinia 
indica and Cucumis callosus have antidiabetic activity 
in GUA. Hypoglycemic effects of Coccinia indica in 
alloxan diabetic albino rats have also been reported19. 
Some herbal formulations are also available for Type 
II diabetes using Coccinia indica extract. Several 
species of Cucurbita such as C. pepo20, C. maxima 
and C. moschata21 were mentioned for antidiabetic 
property in ethnomedicine or tested therapeutically 
for antidiabetic activity in pharmacological studies. 
Cucurbit fruits of the plants Luffa acutangula, 
Momordica charantia, Lagenaria siceraria, Sechium 
edule and Trichosanthes cucumerina from the family 
Cucurbitaceae have been reported for -glucosidase 
inhibitory activity22. Marles and Farnsworth, 1995 
have presented a comprehensive literature review on 
antidiabetic plants and constituents from 
NAPRALERT database up to 1995. They have 
reported about 1200 plant species used for the 
treatment of diabetes and/ or investigated for 
antidiabetic activity. This list of antidiabetic plants 
also include about 30 plant species from 
Cucurbitaceae family21 and some these plant species 
are also evaluated in our studies.  
Numerous species of Luffa is used by traditional 
native practitioners for treatment of various diseases 
and also reported by many researchers. Methanolic 
extract of Luffa echinata seeds showed antioxidant 
activity, anti-inflammatory and analgesic effect in  
in-vivo model23 whereas methanolic extract of  
Luffa acutangula has been reported to be effective  
in treatment of gastric ulcers in diabetic rats24.  
Luffa acutangula fruit extract has also been 
demonstrated antidiabetic and hepatoprotective 
activity in in-vitro and histopathological studies25. 
Here, first time we reported the antidiabetic activity of 
chloroform extract of Luffa echinata fruit in in-vitro 
studies, whereas aqueous and alcoholic extract of 
Luffa echinata fruits are also described for 
antiarthritic activity on Freund’s adjuvant induced 
arthritic rats26. Cucurbitaceae family have enormous 
medicinal value and reported for anxiolytic, 
carminative, antioxidant, anthelmintic, laxative, 
purgative and antidiabetic activity in various 
literature27. Our studies also uphold this view that 
members of family Cucurbitaceae have many 
therapeutically important chemical constituents and 
could be explored extensively for their antidiabetic 
properties. It will also be of interest to evaluate 
further about antidiabetic activity of Luffa echinata 
fruit which could lead to the development of novel 
plant based compound for the treatment of Type II 
diabetes. After taking hint from traditional knowledge 
or folk medicine if we perform targeted screening of 
some specific group of plants then it will be more 
fruitful and rapid for identification of new leads and 
definitely better than random screening for all plants. 
Interestingly we have many plants reported for 
diabetes in Indian literature. The present study was a 
step towards selecting few plant species from a family 
known to have antidiabetic potential in traditional 
medical literature and study those using modern 
scientific tools. The study demonstrated that there is a 
huge potential in the family Cucurbitaceae as far as its 
antidiabetic potential is concerned. The promising 
results on the 4 species i.e. Cucumis callosus fruit, 
Luffa echinata fruit, Coccinia indica fruit and 
Cucurbita species aerial part, out of 9 selected in 
glucose uptake assay have proved this. One species 
Luffa echinata fruit, which showed remarkably high 
antidiabetic activity in our study is to be investigated 
further and might be interesting one. The study 
supported the view that the natural products continue 
to play dominant role in the discovery of leads for the 
development of drugs for alleviating human diseases. 
We believe that a target based approach for screening 
bioactivity of compounds from medicinal plants will 
expedite the drug discovery process and might 
contribute towards identification of interesting/novel 
chemical scaffolds with antidiabetic activity.  
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